Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera

ABSTRACTObjective: Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery of a mutation in the Janus kinase 2 (JAK2V617F), JAK2 inhibitors have been tested as...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Angela Bozza, Martina Bernardi, Daniela Catanzaro, Katia Chieregato, Anna Merlo, Giuseppe Astori
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2023-12-01
Edice:	Hematology
Témata:	Angiotensin-converting enzyme angiotensin-converting enzyme inhibitors angiotensin receptor antagonists polycythemia vera erythrocytosis
On-line přístup:	https://www.tandfonline.com/doi/10.1080/16078454.2023.2182056
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!